Company / Net Income
Traws Pharma, Inc. Net Income History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$166.5M
FY2024
5-year range
-$166.5M / -$16.2M
FY2020-FY2024
Trend
-778.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income changed -778% YoY in FY2024, a notable deviation from the 9-year average annual change of -79%.
Based on SEC 10-K filings.
-$167M in FY2024.
Declined from -$16M to -$167M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, net income decreased 778.1% year-over-year.
- Peak net income was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -42.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$166.5M | -778.1% |
| FY2023 | -$19.0M | -17.3% |
| FY2022 | -$16.2M | +35.8% |
| FY2021 | -$25.2M | -17.0% |
| FY2020 | -$21.5M | -4.5% |
| FY2019 | -$20.6M | +14.6% |
| FY2018 | -$24.1M | -22.5% |
| FY2017 | -$19.7M | +18.0% |
| FY2016 | -$24.0M | +62.3% |
| FY2015 | -$63.7M | -112.9% |
As of FY2024 · SEC 10-K Annual Filings · Last checked Jun 28, 2026